BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

8 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery of Novel Inhibitor Scaffolds against the Metallo-ß-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.EBI
Uit The Arctic University of Norway
In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase- producing Pseudomonas aeruginosa clinical isolates.EBI
Toho University School of Medicine
X-ray Structures of Target-Ligand Complexes Containing Compounds with Assay Interference Potential.EBI
Rheinische Friedrich-Wilhelms-Universit£T
Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.EBI
University of California San Diego
Bismuth(III) compounds and methods thereofBDB
The University of Hong Kong
Therapeutic methods and combinationsBDB
Individual
Metallo-beta-lactamase inhibitors and methods of use thereofBDB
Merck Sharp & Dohme
Exploring the Role of Residue 228 in Substrate and Inhibitor Recognition by VIM Metallo-ß-lactamases.BDB
Louis Stokes Cleveland Veterans Affairs Medical Center